Login

Consolidated balance sheets

In millions of USD, except per-share amounts
Q1 FY2020
As of Mar 31, 2020
Q4 FY2019
As of Dec 31, 2019
Q3 FY2019
As of Sep 30, 2019
Q2 FY2019
As of Jun 30, 2019
Q1 FY2019
As of Mar 31, 2019
Q4 FY2018
As of Dec 31, 2018
Q3 FY2018
As of Sep 30, 2018
Q2 FY2018
As of Jun 30, 2018
Q1 FY2018
As of Mar 31, 2018
Q4 FY2017
As of Dec 31, 2017
Q3 FY2017
As of Sep 30, 2017
Q2 FY2017
As of Jun 30, 2017
Q1 FY2017
As of Mar 31, 2017
Q4 FY2016
As of Dec 31, 2016
Q3 FY2016
As of Sep 30, 2016
Q2 FY2016
As of Jun 30, 2016
Q1 FY2016
As of Mar 31, 2016
Q4 FY2015
As of Dec 31, 2015
Q3 FY2015
As of Sep 30, 2015
Q2 FY2015
As of Jun 30, 2015
ASSETS
Current assets
Cash
Prepaids
Total Current Assets
Total assets
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities
Accounts payable
Accrued liabilities
Wages payable
Accounts payable and accrued liabilities
Unearned revenue
Notes and advances payable
Due to related parties
Derivative liabilities - warrants
Derivative liability - conversion feature
Loans payable
Total Current Liabilities
Total liabilities
Stockholders' deficit
Common stock $0.001 par value, 200,000,000 commonshares authorized, 88,195,005 issued and outstandingat March 31, 2020 and December 31, 2019
Obligation to issue shares
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income
Total stockholders' deficit
Total liabilities and stockholders' deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support